Akeso Biomedical
Waltham
About Akeso Biomedical
Akeso Biomedical is an early-stage company focused on developing new solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds. The Company is developing products to treat these conditions using a new class of compounds, known as Fe3C, that have broad-spectrum activity against a wide range of bacteria, and a silk biomaterial technology exclusively licensed from Tufts University. It was founded in 2014 and headquartered in Waltham, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.3M
- Last round: Series Unknown (Feb 2021)
- Website: akesobiomedical.com
- Phone: (781) 890-0088
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/akeso-biomedical-71747 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.